SCHEMBL14308729

SCHEMBL14308729

C[C@H]1C[C@@]2(CCC(=O)O2)C2(C)C[C@H](O)C3C(CCC4=CC(=O)CCC43C)C12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 9/20 0.54
▸ LMNA P02545 4/20 0.54
▸ NR3C2 P08235 7/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ SERPINA6 P08185 4/20 0.52
▸ HSD17B10 Q99714 3/20 0.52
▸ NR3C1 P04150 3/20 0.52
▸ SHBG P04278 3/20 0.52
▸ PGR P06401 3/20 0.52
▸ CYP3A4 P08684 3/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ NFKB1 P19838 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ HSD11B1 P28845 2/20 0.50
▸ HSD11B2 P80365 2/20 0.50
▸ AR P10275 1/20 0.48
▸ CHRM1 P11229 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14284886 0.86 HIF1A (0.52) HIF1ALMNANR3C2SMN1; SMN2SERPINA6
SCHEMBL14285044 0.85 HIF1A (0.66) HIF1ALMNANR3C2SMN1; SMN2SERPINA6
SCHEMBL14568530 0.85 HIF1A (0.66) HIF1ALMNANR3C2SMN1; SMN2SERPINA6
SCHEMBL20991065 0.84 SHBG (0.54) HIF1ALMNANR3C2SMN1; SMN2SERPINA6
SCHEMBL14318934 0.77 NR3C1 (0.58) HIF1ALMNANR3C2SMN1; SMN2NR3C1
SCHEMBL22367969 0.76 SMN1; SMN2 (0.56) HIF1ALMNANR3C2SMN1; SMN2SERPINA6
SCHEMBL29504095 0.74 SMN1; SMN2 (0.59) HIF1ALMNANR3C2SMN1; SMN2SERPINA6
SCHEMBL8342176 0.73 HIF1A (0.77) HIF1ALMNANR3C2SMN1; SMN2SERPINA6
SCHEMBL6804668 0.73 HIF1A (0.77) HIF1ALMNANR3C2SMN1; SMN2SERPINA6
SCHEMBL9650590 0.73 HIF1A (0.77) HIF1ALMNANR3C2SMN1; SMN2SERPINA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080027237-A1 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein NG JOHN S 2008-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027237-A1 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein CYP4A11, CYP11B1, CYP17A1 HIF1A 2302/4885LMNA 1449/4885NR3C2 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback